Autoimmune APPLICATION NOTES. MyriadRBM.com. Myriad RBM s Biomarker Testing Lab: CLIA Certified ID # 45D Supports GLP Studies
|
|
- Mark Ira Owen
- 5 years ago
- Views:
Transcription
1 I N N O V AT I V E B I O M A R K E R S O L U T I O N S Autoimmune APPLICATION NOTES Myriad RBM s Biomarker Testing Lab: CLIA Certified ID # 45D Supports GLP Studies MyriadRBM.com
2 Autoimmune diseases are chronic and debilitating disorders in which the body mounts an abnormal immune response against its own organs and tissues. With over 8 different identified disorders affecting an estimated 5 million Americans, autoimmune diseases represent an important and growing area for biomarker research 1. Myriad RBM is a leader in the field of biomarker testing, offering comprehensive, quantitative and sensitive measurement of hundreds of protein biomarkers using multi-analyte profiling (MAP ) technology. Our biomarker panels have been a key component of numerous studies covering a variety of autoimmune disorders, including Crohn s disease, rheumatoid arthritis (RA), psoriasis and systemic lupus erythematosus (SLE). Due to the chronic and heterogeneous nature of autoimmune diseases, there is considerable interest in the development of clinical response markers to guide clinicians in tailoring treatments to individual patients. A pair of recent studies on rheumatoid arthritis demonstrate the effectiveness of biomarker profiling in identifying drug responders in clinical trials 2,3. The first of these studies assessed changes in 17 biomarkers in RA patients undergoing treatment with golimumab, a human monoclonal antibody to tumor necrosis factor-alpha (TNF-α), in conjunction with the traditional treatment of methotrexate 2. The authors found multiple markers that were significantly altered after four weeks of drug treatment (Figure 1). Importantly, a subset of these proteins showed promise as biomarkers for predicting clinical response to golimumab. These markers showed a greater decrease from baseline to week 4 of the study in patients who were drug responders at week 14 as compared to non-responders. Additionally, changes from baseline to week 4 in some of the same biomarkers showed strong associations with multiple clinical measures. Similarly, a second study used HumanMAP to determine whether changes in biomarker profiles were associated with traditional measures of disease progression based on radiographic assessments of structural joint damage (van der Heijde-Sharp score) 3. The authors found that radiographic progression of the disease measured from baseline to week 28 of the study was significantly correlated with changes in a number of biomarkers during the early weeks of the trial (Figure 2). In particular, changes in two biomarkers associated with bone remodeling, EGF and CD4L, across the first 4 weeks of the study were associated with large changes in radiographic score at week 28. Together, the findings from these studies suggest that even a relatively short period of biomarker evaluation could be useful in predicting both disease progression and patient response to treatment many weeks later. Both of these RA examples underscore the tremendous value of biomarkers to predict early-stage drug responses, allowing clinicians to more effectively adjust treatments to individual patients.
3 Figure 1: Heatmap showing significant differences between biomarkers at baseline and week 4. Colors represent ranges of mean log2 transformed biomarker levels at each time point. Visvanathan et al. 21 Monocyte-Macrophage-derived chemokine (CCR-4) Lipoprotein(a) Apolipoprotein A1 Insulin Macrophage Inflammatory Protein-1α Tumor Necrosis Factor Receptor II von Willebrand Factor Cancer Antigen 125 Factor VII Leptin Intracellular Adhesion Molecule-1 Adiponectin Interleukin-18 Tissue Inhibitor of Metalloproteinase-1 Matrix Metalloproteinase-3 Monocyte Chemotactic Protein-1 Interleukin-8 Macrophage Inflammatory Protein-1β CD-4 Antigen Serum Amyloid P C-Reactive Protein Haploglobin Epithelial-Derived Neutrophil-Activating Protein 78 Ferritin Myoglobin Serum Glutamic Oxaloacetic Transaminase Vascular Endothelial Growth Factor ENRAGE (S1A12) Myeloperoxidase α-1 Antitrypsin Complement 3 Interleukin-16 Interleukin-1 Receptor Agonist Sex Hormone-Binding Globulin Plasminogen Activator Inhibitor-1 Baseline Week 4 1 mg Placebo 5 mg MTX 1 mg MTX 1 mg Placebo 5 mg MTX 1 mg MTX -2 to to -1-2 to to to.5.5 to 1 1 to to 2 Golimumab Golimumab
4 A Placebo MTX B Placebo MTX Change in vdh-s Score at Week Change in vdh-s Score at Week Change in EGF at Week 4 (pg/ml) Change in CD4 at Week 4 (ng/ml) Progressor Nonprogressor Figure 2: Comparison of change in van der Heijde-Sharp (vdh-s) score (baseline to week 28) with change in (A) EGF levels (baseline to week 4) and (B) CD4 Ligand levels (baseline to week 4) for structural damage progressors and nonprogressors in patients randomized to treatment with placebo MTX. Changes in EGF and CD4L levels across the first 4 weeks of the study were associated with changes in more than 1 in radiographic score at week 28. Wagner et al. 213 Myriad RBM s services have also been used to demonstrate the potential efficacy of novel therapeutic approaches to autoimmune disorders. For example, a recent study involving explanted colonic tissue from patients with Crohn s disease (CD), a form of inflammatory bowel disease (IBD), used InflammationMAP to examine the effects of a novel CD47 fusion protein on an array of pro-inflammatory cytokines and other markers of inflammation 4. Previous studies in mice had found that a CD47 fusion protein confers protection against experimentally induced colitis by suppressing the release of inflammatory cytokines 5. Baba et al. subsequently extended this study to humans. The authors found that inflamed tissue from CD patients showed a clear pro-inflammatory profile compared to controls using a panel of 47 cytokines (Figure 3A). Figure 3A shows the production of cytokines in inflamed tissue plotted against non-inflamed tissue with values above the red line indicating a pro-inflammatory profile.
5 Figure 3: CD47 fusion protein inhibits proinflammatory cytokine release by inflamed intestinal tissue from CD patients. Colonic tissue explants were cultured in the presence of CD47 fusion protein or IgG1 control. The cytokine production profile was examined in the culture supernatants. (A) Scatter plot of cytokine production in non-inflamed (x axis) versus inflamed (y axis) tissues. (B) Scatter plot of cytokine production in explant cultures expressed as the ratio of CD47 fusion protein/igg1 control for inflamed (x axis) versus non-inflamed (y axis) tissues. Values < 1 on the x axis reflect the inhibition by CD47 fusion protein in inflamed tissue. Data are presented as mean of 5 CD patients. Baba et al. 213 A Cytokines (ng or μg from 1mg) from inflamed explant culture B Ratio CD47-Var1/lgG1 control on non-inflamed explant culture Cytokines; p<.1 (Non-inflamed vs. inflamed) Cytokines (ng or μg from 1mg) from non-inflamed explant culture IFN-γ IL-1β IL Ratio CD47-Var1/lgG1 control on inflamed explant culture TNF-α IL-23 MCP-1 MIP-1β MIP-1α IL-8 IL-1 IL-18 Interestingly, exposure to the CD47 fusion protein inhibited the release of many of these cytokines by the inflamed tissue, including IL-1β, -6, -8, -23, TNF-α and IFN-γ, without affecting cytokine release in control tissue from the same patients. Figure 3B shows the effect of treatment with the CD47 fusion protein on cytokine production in non-inflamed versus inflamed tissue. The deviation from the red line but not the blue line indicates an effect of the fusion protein on cytokine release selectively in inflamed tissue only. These findings suggest that administration of the CD47 fusion protein may represent a novel therapeutic approach for CD. The comprehensive biomarker response profile that can be obtained by simultaneously screening dozens of analytes represents a powerful tool for use in both drug discovery and clinical monitoring of drug response. While a number of biomarkers associated with autoimmune diseases have been discovered, there remains a strong need for the identification and validation of blood-based biomarkers of the autoimmune disease process, with the goal of developing a minimally invasive diagnostic or prognostic to guide therapeutic intervention. A number of recent studies analyzing serum samples from patients with autoimmune disorders feature the use of HumanMAP panel in a targeted
6 approach to biomarker discovery 6,7. In one such study, the authors compared serum samples from 26 Systemic Lupus Erythematosus (SLE) patients with samples from healthy controls, finding significantly higher circulating levels of β2-microglobulin (β2mg) in samples from individuals diagnosed with SLE 6. In addition, β2mg levels correlated with a composite measure of disease activity known as the SLE Disease Activity Index (SLEDAI). The SLEDAI is a weighted cumulative index that has been well established as a reliable measure of disease activity in lupus 8. β2mg levels were also correlated with circulating levels of a variety of proteins that are thought to be involved in disease progression, including complement C3, IL-6, -8, -1, -18 and TNF-α (Figure 4). As the course of SLE is highly variable and unpredictable, the identification of serum biomarkers that reliably track disease activity offers tremendous clinical potential. A 25 B 25 Beta-2 Microglobulin (mg/l) Beta-2 Microglobulin (mg/l) SLEDAI C3 (g/l) Figure 4: Scatter plot of serum levels of β2mg and disease activity measured as (A) SLEDAI and (B) Complement C3 in 26 patients with SLE. Correlation: (A) R =.68, p <.1, (B) R = -.52, p =.7. Hermansen et al. 212 All together, these studies highlight the effectiveness of using Myriad RBM s multiplexed immunoassays for the quantitative measurement of a large number of analytes within an individual study. Further characterization of the biomarker profiles related to the progression and treatment of autoimmune diseases promises to make significant contributions to diagnosis and therapeutics. Myriad RBM strives to be a leading provider of biomarker assays for research on autoimmune disorders.
7 1. The Cost Burden of Autoimmune Disease: The Latest Front in the War on Healthcare Spending. American Autoimmune Related Diseases Association (AARDA) and the National Coalition of Autoimmune Patient Groups (NCAPG). (211). 2. Visvanathan S, Rahman MU, Keystone E, Genovese M, Klareskog L, Hsia E, Mack M, Buchanan J, Elashoff M, Wagner C. Association of serum markers with improvements in clinical response measures after treatment with golimumab in patients with active rheumatoid arthritis despite receiving methotrexate: results from the GO-FORWARD study. Arthritis Res Ther. (21) 12(6):R Wagner C, Chen D, Fan H, Hsia EC, Mack M, Emery P, Fleischmann RM. Evaluation of serum biomarkers associated with radiographic progression in methotrexate-naïve rheumatoid arthritis patients treated with methotrexate or golimumab. J Rheumatol. (213) 4(5): Baba N, Van VQ, Wakahara K, Rubio M, Fortin G, Panzini B, Soucy G, Wassef R, Richard C, Tamaz R, Lahaie R, Bernard EJ, Caussignac Y, Leduc R, Lougnarath R, Bergeron C, Racicot MA, Bergeron F, Panzini MA, Demetter P, Franchimont D, Schakel K, Weckbecker G, Kolbinger F, Heusser C, Huber T, Welzenbach K, Sarfati M. CD47 fusion protein targets CD172a cells in Crohn s disease and dampens the production of IL-1β and TNF. J Exp Med. (213) 21(6): Fortin G, Raymond M, Van VQ, Rubio M, Gautier P, Sarfati M, Franchimont D. A role for CD47 in the development of experimental colitis mediated by SIRPαCD13- dendritic cells. Journal of Experimental Medicine. (29) 26(9): Hermansen ML, Hummelshoj L, Lundsgaard D, Hornum L, Keller P, Fleckner J, Fox B, Poulsen LK, Jacobsen S. Increased serum β2-microglobulin is associated with clinical and immunological markers of disease activity in systemic lupus erythematosus patients. Lupus. (212) 21(1): Suarez-Farinas M, Li K, Fuentes-Duculan J, Hayden K, Brodmerkel C, Kreuger J. Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis. J Invest Dermatol. (212) 132(11): Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. (1992) 35(6):63-4.
8 Myriad RBM, Inc. 33 Duval Road Austin, Texas P Toll-free 866 RBM MAPS ( ) F REV 1
APPLICATION NOTES Myriad RBM s Biomarker Testing Lab:
I N N O V AT I V E B I O M A R K E R S O L U T I O N S Inflammation APPLICATION NOTES Myriad RBM s Biomarker Testing Lab: CLIA Certified ID # 45D137483 Supports GLP Studies MyriadRBM.com Table of Contents
More informationAUTOANTIBODY SYSTEM. Detect Quantify Classify PROFILING. ITSI Biosciences LLC 633 Napoleon Street Johnstown, PA 15901, USA.
AUTOANTIBODY PROFILING SYSTEM ITSI Biosciences LLC 633 Napoleon Street Johnstown, PA 15901, USA. Detect Quantify Classify Phone: +1-814-262-7331; Fax: +1-814-262-7334, Email: itsi@itsibio.com Website:
More informationIL-17 in health and disease. March 2014 PSO13-C051n
IL-17 in health and disease March 2014 PSO13-C051n Originally Researchers Suggested That IL-12 and IL-4 drove Th Cell Differentiation Naïve CD4 + T cell Question: Which of these cell types is responsible
More informationTh17 Pathway Research By Bio-Plex
Th17 Pathway Research By Bio-Plex Zhiyang Shen, Senior Product Manager Bio-Rad Laboratories, Inc 2011 年 6 月 28 日星期二 T helper cell research Timeline: advances on T helper research. Figure depicts some of
More informationSpeciality and Research Controls
Controls Speciality and Research Product Range Product Antimicrobial Array 1 Plus Control 3 x 1 ml AMC5084 Antimicrobial Control II 3 x 1 ml AMC5035 Antimicrobial Control III 3 x 1 ml AMC5036 Growth Promoter
More informationAssessing Changes In Biomarkers Of Effect In Smokers Who Switch To A Closed System Electronic Cigarette. Liz Mason Kunming, China 26 th October 2018
Assessing Changes In Biomarkers Of Effect In Smokers Who Switch To A Closed System Electronic Cigarette Liz Mason Kunming, China 26 th October 2018 CONTENT 1. Background Biomarkers of exposure and effect
More information?Who binds to it. ? Who binds these inflammatory proteins RAGE SUGAR-FREE GLYCOBIOLOGY INFLAMMATION. BASIC SCIENCE?sugar chain structure
SUGAR-FREE GLYCOBIOLOGY BASIC SCIENCE?sugar chain structure Unusual Sugar Chain It -- is a carboxylate Make lots of It Make an It antibody Inflammatory proteins?who binds to it? Who binds these inflammatory
More informationDNA vaccine, peripheral T-cell tolerance modulation 185
Subject Index Airway hyperresponsiveness (AHR) animal models 41 43 asthma inhibition 45 overview 41 mast cell modulation of T-cells 62 64 respiratory tolerance 40, 41 Tregs inhibition role 44 respiratory
More informationFOR OPTIMAL GUT HEALTH KEMIN.COM/GUTHEALTH
FOR OPTIMAL GUT HEALTH KEMIN.COM/GUTHEALTH ALETA A SOURCE OF 1,3-BETA GLUCANS Aleta is highly bioavailable, offering a concentration greater than 5% of 1,3-beta glucans. Aleta provides a consistent response
More informationMOLECULAR IMMUNOLOGY Manipulation of immune response Autoimmune diseases & the pathogenic mechanism
MOLECULAR IMMUNOLOGY Manipulation of immune response Autoimmune diseases & the pathogenic mechanism SCHMAIEL SHIRDEL CONTENT 2 Introduction Autoimmune diseases Classification Involved components Autoimmune
More informationEffector T Cells and
1 Effector T Cells and Cytokines Andrew Lichtman, MD PhD Brigham and Women's Hospital Harvard Medical School 2 Lecture outline Cytokines Subsets of CD4+ T cells: definitions, functions, development New
More informationAttribution: University of Michigan Medical School, Department of Microbiology and Immunology
Attribution: University of Michigan Medical School, Department of Microbiology and Immunology License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution
More informationImmunology lecture: 14. Cytokines: Main source: Fibroblast, but actually it can be produced by other types of cells
Immunology lecture: 14 Cytokines: 1)Interferons"IFN" : 2 types Type 1 : IFN-Alpha : Main source: Macrophages IFN-Beta: Main source: Fibroblast, but actually it can be produced by other types of cells **There
More informationPsoriasis and the metabolic syndrome
Psoriasis and the metabolic syndrome MD, PhD James G. Krueger 1 Inflammation as a foundation of metabolic dysregulation and cardiovascular disease risk Diseases of systemic immune activation and inflammation,
More informationAssociation between serum interleukin-17a and clinical response to tofacitinib and etanercept in moderate to severe psoriasis
Original article CED Clinical and Experimental Dermatology Association between serum interleukin-17a and clinical response to tofacitinib and etanercept in moderate to severe psoriasis L. Fitz, 1 W. Zhang,
More informationAutoimmune Diseases. Betsy Kirchner CNP The Cleveland Clinic
Autoimmune Diseases Betsy Kirchner CNP The Cleveland Clinic Disclosures (financial) No relevant disclosures Learning Objectives Explain the pathophysiology of autoimmune disease Discuss safe administration
More informationgolimumab (Simponi Aria, Simponi )
Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided
More informationGolimumab: In Combination with Methotrexate as Once Monthly Treatment for Moderate to Severe Rheumatoid Arthritis
Clinical Medicine Reviews in Therapeutics Review Golimumab: In Combination with Methotrexate as Once Monthly Treatment for Moderate to Severe Rheumatoid Arthritis Lauren Keyser McCluggage 1 and Kelly Michelle
More informationACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS. Choompone Sakonwasun, MD (Hons), FRCPT
ACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS Choompone Sakonwasun, MD (Hons), FRCPT Types of Adaptive Immunity Types of T Cell-mediated Immune Reactions CTLs = cytotoxic T lymphocytes
More informationFirePlex Multiplex Immunoassay product list
FirePlex Multiplex Immunoassay product list Contents Purchasing the assay Human - pre-designed panels Human list of analytes Human protein standard mixes Mouse - pre-designed panels Mouse list of analytes
More informationElaborating ELAD Mechanism of Action and Linking Cell-Based Models to the Clinic
Elaborating ELAD Mechanism of Action and Linking Cell-Based Models to the Clinic September 9, 2017 Patricia W Bedard, Jason Lapetoda, Jagadeesha Dammanahalli, Jessica Van Allen, Susan Lin, Lee Landeen
More informationImmune response to infection
Immune response to infection Dr. Sandra Nitsche (Sandra.Nitsche@rub.de ) 20.06.2018 1 Course of acute infection Typical acute infection that is cleared by an adaptive immune reaction 1. invasion of pathogen
More informationImmunology for the Rheumatologist
Immunology for the Rheumatologist Rheumatologists frequently deal with the immune system gone awry, rarely studying normal immunology. This program is an overview and discussion of the function of the
More informationMicrobiology 204: Cellular and Molecular Immunology
Microbiology 204: Cellular and Molecular Immunology Class meets MWF 1:00-2:30PM (*exceptions: no class Fri Sept 23, Fri Oct 14, Nov 11, or Wed Nov 23) Lectures are open to auditors and will be live-streamed
More informationImmunological biomarkers predictive of clinical response to chemotherapy and maintenance HAART in HIV + patients with Kaposi sarcoma
P909 Immunological biomarkers predictive of clinical response to chemotherapy and maintenance HAART in HIV + patients with Kaposi sarcoma Tedeschi R, Bidoli E 2, Bortolin MT, Pratesi C, Basaglia G, Zanussi
More informationCutaneous Immunology: Innate Immune Responses. Skin Biology Lecture Series
Cutaneous Immunology: Innate Immune Responses Skin Biology Lecture Series The Immune Response: Innate and Adaptive Components Source: Wolff, Goldsmith, Katz, Gilchrest, Paller, Leffell. Fitzpatrick s Dermatology
More informationThe Immune System: The Mind Body Connection. Presented by Margaret Kemeny, Ph.D. Department of Psychiatry, University of California, San Francisco
The Immune System: The Mind Body Connection Presented by Margaret Kemeny, Ph.D. Department of Psychiatry, University of California, San Francisco Psychoneuroimmunology Investigation of the bidirectional
More informationPristane Induced Lupus Model
Pristane Induced Lupus Model Systemic lupus erythematosus (SLE) is an autoimmune inflammatory disease of unknown etiology, and for which approved therapies are inadequate. Current treatments rely on the
More informationConcept of Spondyloarthritis (SpA)
Concept of Spondyloarthritis (SpA) Spondyloarthritis: Characteristic Parameters Used for Diagnosis I Symptoms Inflammatory back pain Imaging Lab ESR/CRP Patient s history Good response to NSAIDs Spondyloarthritis-Characteristic
More informationTolerance, autoimmunity and the pathogenesis of immunemediated inflammatory diseases. Abul K. Abbas UCSF
Tolerance, autoimmunity and the pathogenesis of immunemediated inflammatory diseases Abul K. Abbas UCSF Balancing lymphocyte activation and control Activation Effector T cells Tolerance Regulatory T cells
More informationT cell-mediated immunity
T cell-mediated immunity Overview For microbes within phagosomes in phagocytes.cd4+ T lymphocytes (TH1) Activate phagocyte by cytokines studies on Listeria monocytogenes For microbes infecting and replicating
More informationSUPPLEMENTARY METHODS
SUPPLEMENTARY METHODS Histological analysis. Colonic tissues were collected from 5 parts of the middle colon on day 7 after the start of DSS treatment, and then were cut into segments, fixed with 4% paraformaldehyde,
More informationAVAILABLE BIOMARKER ASSAYS
AAILABLE BIOMARKER ASSAYS alidation Alpha-2-microglobulin ELISA Anti-CD71/anti-platelet/propidium iodide Anti-KLH IgG ELISA,, Dog, Minipig, Apoptotic, necrotic and dead cells (bone marrow) B (activated
More informationCytokines modulate the functional activities of individual cells and tissues both under normal and pathologic conditions Interleukins,
Cytokines http://highered.mcgraw-hill.com/sites/0072507470/student_view0/chapter22/animation the_immune_response.html Cytokines modulate the functional activities of individual cells and tissues both under
More informationSarcoidosis: is there a role for anti-tnf-α?
Sarcoidosis: is there a role for anti-tnf-α? Abstract In severe cases of sarcoidosis treatment can be very difficult. The common treatment strategies might be failing. Tumour necrosis factor (TNF) α therapy
More information10/25/2018. Autoimmunity and how to treat it. Disclosure. Why do we get autoimmunity? James Verbsky MD/PhD Pediatric Rheumatology/Immunology
Autoimmunity and how to treat it James Verbsky MD/PhD Pediatric Rheumatology/Immunology Disclosure None I will mention drug names and some brand names but I have no financial interest or any other ties
More informationBiomarkers in drug discovery and development. Margit Wissenbach, PhD Dir Business Development Scandinavia
Biomarkers in drug discovery and development Margit Wissenbach, PhD Dir Business Development Scandinavia Aptuit: A Truly Integrated R&D Offering Integrated Discovery Integrated Development IND Candidate
More informationGender Differences in Autoimmune Diseases
//9 Impact of Gender on the Pathogenesis of Crohn s Disease Theresa T. Pizarro Department of Pathology, CWRU Gender Differences in Autoimmune Diseases n Autoimmune diseases affect ~.7-. million people
More informationCell-mediated Immunity
Cellular & Molecular Immunology Cell-mediated Immunity Nicholas M. Ponzio, Ph.D. Department of Pathology & Laboratory Medicine April 6, 2009 Today s Presentation: Overview Cellular Interactions In Humoral
More informationPredicting Response to Intravesical Immunotherapy (BCG) in NMIBC
Predicting Response to Intravesical Immunotherapy (BCG) in NMIBC Ashish M. Kamat, MD, MBBS, FACS Professor of Urologic Oncology Wayne B. Duddlesten Professor of Cancer Research President, International
More informationCellular Immune response. Jianzhong Chen, Ph.D Institute of immunology, ZJU
Cellular Immune response Jianzhong Chen, Ph.D Institute of immunology, ZJU Concept of adaptive immune response T cell-mediated adaptive immune response I. Concept of immune response A collective and coordinated
More informationAutoimmunity. Autoimmunity arises because of defects in central or peripheral tolerance of lymphocytes to selfantigens
Autoimmunity Autoimmunity arises because of defects in central or peripheral tolerance of lymphocytes to selfantigens Autoimmune disease can be caused to primary defects in B cells, T cells and possibly
More informationHIV AND INFLAMMATION: A NEW THREAT
HIV AND INFLAMMATION: A NEW THREAT KAP ANNUAL SCIENTIFIC CONFERENC MAY 2013 DR JOSEPH ALUOCH FRCP,EBS Basic Components of the Immune System Immunology: cells and tissues involved in recognizing and attacking
More informationMAF Shalaby Prof. Rheumatology Al Azhar University, Cairo, Egypt.
MAF Shalaby Prof. Rheumatology Al Azhar University, Cairo, Egypt. AUTOIMMUNE DISEASE RA SLE VASCULITIS RELAPSING POLYCHONDRITIS SS DM/PM SJOGREN S SYNDROME RHEUMATOID ARTHRITIS Classically immune mediated
More informationare associated with sickle cell disease and carriers: a study of patients from the southeastregion of Iran
CXC chemokines CXCL1, CXCL9, CXCL10 and CXCL12 are associated with sickle cell disease and carriers: a study of patients from the southeastregion of Iran Mojgan Noroozi Karimabad Molecular Medicine Research
More informationInflammation in the clinic
Inflammation in the clinic Stephen T. Holgate MRC Clinical Professor of Immunopharmacology ILSI Europe Workshop, Seville, May 14-15 2012 The immune system acts in four general ways to ensure host defence
More informationThe Pathogenesis of Bone Erosions in RA FULL VERSION
The Pathogenesis of Bone Erosions in RA FULL VERSION 1 Key Learning Objectives Understand the role of osteoclasts in normal bone remodeling Comprehend the key processes in pathologic osteoclast functions
More informationAlida R Harahap & Farida Oesman Department of Clinical Pathology Faculty of Medicine, University of Indonesia
Alida R Harahap & Farida Oesman Department of Clinical Pathology Faculty of Medicine, University of Indonesia Foreign molecules = antigens Immune response Immune system non-specific specific cellular humoral
More informationRaised serum IL-8 levels are associated with excessive fatigue in female carriers of X-linked Chronic Granulomatous Disease in the United Kingdom
Raised serum IL-8 levels are associated with excessive fatigue in female carriers of X-linked Chronic Granulomatous Disease in the United Kingdom Battersby A 1, Martin AJ 1, Tarn J 1, Ng WF 1, Cale C 2,
More informationPrincipal Investigator. General Information. Conflict of Interest. Certification Published on The YODA Project (
Principal Investigator First Name: Liana Last Name: Fraenkel Degree: MD, MPH Primary Affiliation: Yale University School of Medicine E-mail: christine.ramsey@gmail.com Phone number: 610-613-6745 Address:
More informationBasis of Immunology and
Basis of Immunology and Immunophysiopathology of Infectious Diseases Jointly organized by Institut Pasteur in Ho Chi Minh City and Institut Pasteur with kind support from ANRS & Université Pierre et Marie
More informationHepatic Inflammation and Cellular Therapy
Hepatic Inflammation and Cellular Therapy Lee K. Landeen, Jessica Van Allen, Patricia W. Bedard Vital Therapies, Inc., San Diego, CA, USA Alcoholic Hepatitis: Role of Inflammation Inflammatory Mediators
More informationBiomarker Discovery: Prognosis and Management of Chronic Diabetic Foot Ulcers
Biomarker Discovery: Prognosis and Management of Chronic Diabetic Foot Ulcers Joseph Colasurdo, BS Dr. William M. Scholl College of Podiatric Medicine July 29, 2017 S Disclosure of Conflicts of Interest
More informationSupplementary Figure 1. Characterization of basophils after reconstitution of SCID mice
Supplementary figure legends Supplementary Figure 1. Characterization of after reconstitution of SCID mice with CD4 + CD62L + T cells. (A-C) SCID mice (n = 6 / group) were reconstituted with 2 x 1 6 CD4
More informationDarwinian selection and Newtonian physics wrapped up in systems biology
Darwinian selection and Newtonian physics wrapped up in systems biology Concept published in 1957* by Macfarland Burnet (1960 Nobel Laureate for the theory of induced immune tolerance, leading to solid
More informationChronic Granulomatous Disease Managing GI Issues
Chronic Granulomatous Disease Managing GI Issues N I C H O L A S H A R T O G, M D D i r e c t o r o f P e d i a t r i c / A d u l t P r i m a r y I m m u n o d e f i c i e n c y C l i n i c A s s i s t
More informationThe Adaptive Immune Responses
The Adaptive Immune Responses The two arms of the immune responses are; 1) the cell mediated, and 2) the humoral responses. In this chapter we will discuss the two responses in detail and we will start
More informationPotential Role of Sphingosine 1-Phosphate in the. Pathogenesis of Rheumatoid Arthritis
Potential Role of Sphingosine 1-Phosphate in the Pathogenesis of Rheumatoid Arthritis COMMENTARY for Zhao, C., Fernandes, M.J., Turgeon, M., Tancrede, S., Di Battista, J., Poubelle, P.E. and Bourgoin,
More informationT Cell Effector Mechanisms I: B cell Help & DTH
T Cell Effector Mechanisms I: B cell Help & DTH Ned Braunstein, MD The Major T Cell Subsets p56 lck + T cells γ δ ε ζ ζ p56 lck CD8+ T cells γ δ ε ζ ζ Cα Cβ Vα Vβ CD3 CD8 Cα Cβ Vα Vβ CD3 MHC II peptide
More informationPart III Innate and Adaptive Immune Cells: General Introduction
Innate and Adaptive Immune Cells: General Introduction Iván López-Expósito As an organ specialized in food digestion and nutrient absorption, the intestinal mucosa presents a huge surface area (almost
More informationImmunological Aspect of Ozone in Rheumatic Diseases
Immunological Aspect of Ozone in Rheumatic Diseases Prof. Dr. med. Z. Fahmy Chief Consulting Rheumatologist Augusta Clinic for Rheumatic Diseases And Rehabilitation Bad Kreuznach Germany Rheumatoid arthritis
More informationPrinciples of Adaptive Immunity
Principles of Adaptive Immunity Chapter 3 Parham Hans de Haard 17 th of May 2010 Agenda Recognition molecules of adaptive immune system Features adaptive immune system Immunoglobulins and T-cell receptors
More informationIMO-8400, a novel TLR7, TLR8 and TLR9 antagonist, psoriasis
IMO-8400, a novel TLR7, TLR8 and TLR9 antagonist, inhibits disease development in mouse models of psoriasis Weiwen e Ja Jiang, Fu-Gang Zhu, Dong Yu, Ekambar R. Kandimalla, a a, Nicola La Monica, and Sudhir
More informationCorrelation between Systemic Lupus Erythematosus Disease Activity Index, C3, C4 and Anti-dsDNA Antibodies
Original Article Correlation between Systemic Lupus Erythematosus Disease Activity Index, C3, C4 and Anti-dsDNA Antibodies Col K Narayanan *, Col V Marwaha +, Col K Shanmuganandan #, Gp Capt S Shankar
More informationCD40L TCR IL-12 TLR-L
CD40L B cells plasmacells Neutrophils TCR inkt cells IL-12 Ab production Can inkt cells modulate the cytokine profile of neutrophils? TLR-L CD4+ and CD8+ T cell responses 1. The invariant TCR expressed
More informationAmerican College of Rheumatology Analyst and Investor Meeting November 6, 2011
American College of Rheumatology 2011 Analyst and Investor Meeting November 6, 2011 Chuck Triano Senior Vice President, Investor Relations Forward-Looking Statements Our discussions during this meeting
More informationCytokines, adhesion molecules and apoptosis markers. A comprehensive product line for human and veterinary ELISAs
Cytokines, adhesion molecules and apoptosis markers A comprehensive product line for human and veterinary ELISAs IBL International s cytokine product line... is extremely comprehensive. The assays are
More informationBiomarkers of inflammation in human nutrition studies
NIHR Southampton Biomedical Research Centre in nutrition Biomarkers of inflammation in human nutrition studies Philip Calder Professor of Nutritional Immunology University of Southampton The NIHR Southampton
More informationChapter 13: Cytokines
Chapter 13: Cytokines Definition: secreted, low-molecular-weight proteins that regulate the nature, intensity and duration of the immune response by exerting a variety of effects on lymphocytes and/or
More informationUSTEKINUMAB and BRIAKINUMAB
USTEKINUMAB and BRIAKINUMAB Andrew Blauvelt, M.D. Professor, Dept. of Dermatology and Dept. of Molecular Microbiology & Immunology Oregon Health & Science University Chief, Dermatology Service Veteran
More informationBiologic agents in Internal Medicine-2018: Targeted therapies for.
Biologic agents in Internal Medicine-2018: Targeted therapies for. Chronic inflammatory diseases affecting the skin Chronic inflammatory diseases affecting the gut Chronic inflammatory diseases affecting
More informationAutoimmune diseases, their pathogenic mechanisms and treatment of unwanted immune responses (Janeway s Immunobiology)
Autoimmune diseases, their pathogenic mechanisms and treatment of unwanted immune responses (Janeway s Immunobiology) Picture source: https://www.klini kum.uniheidelberg.de/fil eadmin/pressest elle/pm_neu/20
More informationFaecalibacterium prausnitzii
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients PNAS 105(43): 16731-16736, 2008. Speaker: Ming-Cheng Chen Advisor:
More informationCathepsin S Inhibitors for the Treatment of Inflammatory Bowel Disease. Therapeutic Area Partnerships Presentation.
Inhibitors for the Treatment of Inflammatory Bowel Disease Therapeutic Area Partnerships Presentation November 29, 2012 Cathepsin Cysteine Proteinases Fibrosis Cathepsin O Cathepsin B Cathepsin C Cathepsin
More informationHow the Innate Immune System Profiles Pathogens
How the Innate Immune System Profiles Pathogens Receptors on macrophages, neutrophils, dendritic cells for bacteria and viruses Broad specificity - Two main groups of bacteria: gram positive, gram-negative
More informationPotential Rebalancing of the Immune System by Anti-CD52 Therapy
Potential Rebalancing of the Immune System by Anti-CD52 Therapy Johanne Kaplan, PhD VP Neuroimmunology Research Genzyme March 26, 2013 RESTRICTED USE SEE TRAINING MEMO 2011 DO Genzyme NOT 1COPY Corporation
More informationThe Immune Response in Time and Space
The Immune Response in Time and Space Chapters 14 & 4 Sharon S. Evans, Ph.D. Department of Immunology 845-3421 sharon.evans@roswellpark.org September 18 & 23, 2014 Inflammation Inflammation Complex response
More informationCytokines. Luděk Šefc. Cytokines Protein regulators of cellular communication. Cytokines x hormones
Cytokines Luděk Šefc Cytokines Protein regulators of cellular communication Cytokines x hormones Hormones Cytokines Production sites few many Cell targets few many Presence in blood yes rarely Biological
More informationRheumatology and Internal Diseases Clinic of the Central Clinical Hospital in Warsaw 137 Woloska St. WARSAW POLAND prof. Małgorzata Wisłowska
Rheumatology and Internal Diseases Clinic of the Central Clinical Hospital in Warsaw 137 Woloska St. WARSAW 02-507 POLAND prof. Małgorzata Wisłowska MD, PhD 1 Klinika Chorób Wewnętrznych i Reumatologii
More informationIBD Tools to Aid in the Accurate Diagnosis of Inflammatory Bowel Disease
IBD Tools to Aid in the Accurate Diagnosis of Inflammatory Bowel Disease Inflammatory Bowel Disease Experts in Autoimmunity Inova Diagnostics offers a complete array of methods to aid in the diagnosis
More informationUniversity of Groningen. Hidradenitis suppurativa Dickinson-Blok, Janine Louise
University of Groningen Hidradenitis suppurativa Dickinson-Blok, Janine Louise IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check
More informationIKKα Causes Chromatin Modification on Pro-Inflammatory Genes by Cigarette Smoke in Mouse Lung
IKKα Causes Chromatin Modification on Pro-Inflammatory Genes by Cigarette Smoke in Mouse Lung Se-Ran Yang, Samantha Valvo, Hongwei Yao, Aruna Kode, Saravanan Rajendrasozhan, Indika Edirisinghe, Samuel
More informationToll-like Receptors (TLRs): Biology, Pathology and Therapeutics
Toll-like Receptors (TLRs): Biology, Pathology and Therapeutics Dr Sarah Sasson SydPATH Registrar 23 rd June 2014 TLRs: Introduction Discovered in 1990s Recognise conserved structures in pathogens Rely
More informationChapter 3, Part A (Pages 37-45): Leukocyte Migration into Tissues
Allergy and Immunology Review Corner: Chapter 3, Part A (pages 37-45) of Cellular and Molecular Immunology (Seventh Edition), by Abul K. Abbas, Andrew H. Lichtman and Shiv Pillai. Chapter 3, Part A (Pages
More informationNaive, memory and regulatory T lymphocytes populations analysis
Naive, memory and regulatory T lymphocytes populations analysis Jaen Olivier, PhD ojaen@beckmancoulter.com Cellular Analysis application specialist Beckman Coulter France Introduction Flow cytometric analysis
More informationSupplemental Figure 1. IL-3 blockade with Fab CSL362 depletes plasmacytoid dendritic cells (pdcs), but not basophils, at higher doses.
Supplemental Figure 1. IL-3 blockade with Fab CSL362 depletes plasmacytoid dendritic cells (pdcs), but not basophils, at higher doses. Percentage of viable (A) pdcs (Sytox Blue-, Lin1-, HLADR+, BDCA2++)
More informationNew and Emerging Therapies in IBD. Sarah Streett MD, AGAF Clinical Associate Professor of Medicine Stanford University
New and Emerging Therapies in IBD Sarah Streett MD, AGAF Clinical Associate Professor of Medicine Stanford University New and Emerging Therapies in IBD I have no relevant financial disclosures. IBD is
More informationCytokines (II) Dr. Aws Alshamsan Department of Pharmaceu5cs Office: AA87 Tel:
Cytokines (II) Dr. Aws Alshamsan Department of Pharmaceu5cs Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa Learning Objectives By the end of this lecture you will be able to: 1 Understand the physiological
More informationInnate immune regulation of T-helper (Th) cell homeostasis in the intestine
Innate immune regulation of T-helper (Th) cell homeostasis in the intestine Masayuki Fukata, MD, Ph.D. Research Scientist II Division of Gastroenterology, Department of Medicine, F. Widjaja Foundation,
More informationNew evidences. Biomarkers to explore immunoparalysis: what future for immunostimulation? B. François CHU Limoges (France)
New evidences Biomarkers to explore immunoparalysis: what future for immunostimulation? B. François CHU Limoges (France) Background Hotchkiss, NEJM 2003 New understanding of response in sepsis PICS Persistent
More informationLondon, 1 June 2006 Product name: REMICADE Procedure number: Remicade-H-240-II-73-AR SCIENTIFIC DISCUSSION 1/8
London, 1 June 2006 Product name: REMICADE Procedure number: Remicade-H-240-II-73-AR SCIENTIFIC DISCUSSION 1/8 1. Introduction Infliximab is a chimeric human-murine IgG1κ monoclonal antibody, which binds
More informationPrimary Results Citation 2
Table S1. Adalimumab clinical trials 1 ClinicalTrials.gov Rheumatoid Arthritis 3 NCT00195663 Breedveld FC, Weisman MH, Kavanaugh AF, et al. The PREMIER study. A multicenter, randomized, double-blind clinical
More informationOrencia (abatacept) for Rheumatoid Arthritis. Media backgrounder
Orencia (abatacept) for Rheumatoid Arthritis Media backgrounder What is Orencia (abatacept)? Orencia (abatacept) is the first biologic agent to be available in both an intravenous (IV) and a self-injectable,
More informationNEUTROPHIL, BASOPHIL, EOSINOPHIL, AND PLATELETS SURFACE RECEPTORS
LECTURE: 15 Title NEUTROPHIL, BASOPHIL, EOSINOPHIL, AND PLATELETS SURFACE RECEPTORS LEARNING OBJECTIVES: The student should be able to: Determine the relative percentages in blood for the various types
More informationRequirements in the Development of an Autoimmune Disease Amino Acids in the Shared Epitope
+ T cell MHC/self-peptide MHC/Vβ Induction of + T H 1 mediated autoimmunity: A paradigm for the pathogenesis of rheumatoid arthritis, multiple sclerosis and type I diabetes APC Activated autoreactive +
More informationPeter H. Schafer, 1 Peng Chen, 2 Lorraine Fang, 2 Andrew Wang, 2 and Rajesh Chopra Introduction
Journal of Immunology Research Volume 215, Article ID 963, 1 pages http://dx.doi.org/1.1155/215/963 Clinical Study The Pharmacodynamic Impact of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, on Circulating
More informationNew therapeutic targets for T2DM
New therapeutic targets for T2DM Targeting inflammation: NF- B, salsalate Gwanpyo Koh Department of Internal Medicine Jeju National University School of Medicine Introduction Obesity is occurring at epidemic
More informationSupplementary Figure 1
Supplementary Figure 1 Identification of IFN-γ-producing CD8 + and CD4 + T cells with naive phenotype by alternative gating and sample-processing strategies. a. Contour 5% probability plots show definition
More informationCD137 Pathway: Immunology and Diseases
CD137 Pathway: Immunology and Diseases CD137 Pathway: Immunology and Diseases Edited by LIEPING CHEN John Hopkins University Baltimore, MD, USA Editor: Lieping Chen Department of Dermatology and Oncology
More informationControl of intestinal inflammation by regulatory T cells
Control of intestinal inflammation by regulatory T cells Fiona Powrie Sir William Dunn School of Pathology University of Oxford fiona.powrie@path.ox.ac.uk Regulatory T cells prevent immune pathology in
More information